![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, May 10, 2020 5:19:17 AM
Evaluate
Sunday, 10/22/17 02:31:21 AM
Re: None
Post # of 282119
A couple other Sawston docs I stumbled across (while I was looking for the site acreage):
http://plan.scambs.gov.uk/swiftlg/MediaTemp/1134366-522858.pdf
includes:
Involvement
The following consultants have been involved in the preparation of this application:
DTZ – Planning Consultants
AHP – Architects
PJC - Ecology
MBC Traffic – Transport Consultants
SMP – Consulting Engineers
Consultation
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135592905
Friday, 11/17/17
longfellow95
Friday, 11/17/17 06:13:53 AM
Re: tencoin post# 143391
Post # of 282119
ahpltd.co.uk/cell-therapy-laboratories/
Quote:AHP are pleased to have been instructed by a leading Bio Science company in the development of a new commercial validated GMP compliant manufacturing facility and state of the art Research and Development Laboratories in South Cambridge. Our client has extensive experience in the development of cell-based therapeutics in the USA and are now developing the first commercial scale manufacturing facility in England.
.
The South Cambridge Site offers the opportunity for further expansion and the vision is for the development of a healthcare campus providing both manufacturing and patient treatment in the same locality.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136271773
A few months ago???
AHP Architects & Surveyors Ltd
Architecture & Planning Sevenoaks, Kent
Genetic and Cellular Therapy Laboratories
Private client.
scheme
Genetic and Cellular Therapy Laboratories
client
Undisclosed
value
£18m
description
AHP were appointed as lead designer for the refurbishment of an existing distribution depot and associated offices. The refurbishment provided the client with state of the art genetic and cellular therapy, GMP manufacturing facilities in class D, C and B cleanroom laboratories with associated accommodation, including temperature-controlled quarantine storage, microbiology testing laboratories, process development laboratories, cryogenic shipping, secure data storage, administration offices, staff recreation and changing areas.
The design also included 4 rentable ‘hotel’ suites for start-up projects. Each self-contained unit includes laboratory and EM microbiology facilities, and administration space.
https://www.ahpltd.co.uk/genetherapy
https://www.ahpltd.co.uk/mobile-genetherapy (Cambridge)
https://www.ahpltd.co.uk/
Note:
Project:
Cell Therapy Laboratories
Royal Free Hospital
https://www.ahpltd.co.uk/celltherapy
https://www.ahpltd.co.uk/mobile-celltherapy
scheme
Cell Therapy Laboratories
Royal Free Hospital
client
Royal Free London NHS Foundation Trust
value
£2.1m
description
The scheme comprised increasing University College London’s world-leading cell therapy laboratories facility at the Royal Free Hospital, from four cleanroom labs to ten with multiple cleanroom classifications. The rooms require carefully sequenced air pressure cascade and make use of cutting edge partitioning systems from Italy.
The scheme was developed by an expert design team through extensive workshops with the end user and hospital Trust. The project was split into three phases, organised around the continuing laboratory function within the live hospital environment.
News:
New laboratories open.
20 March 2015
Comment:
Mark Lowdell
https://www.royalfree.nhs.uk/news-media/news/new-laboratories-open/
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM